Lower systemic blood pressure, measured by 24-hour ambulatory monitoring, is significantly associated with faster visual field progression in glaucoma

A subretinal injection gene therapy for Bietti crystalline dystrophy shows a potential for improving visual acuity

Mefunidone, an antifibrotic compound, can prevent the development of posterior capsular opacification in mice

A novel complement-inhibitor gene therapy showed reasonable safety and tolerability in a phase-one clinical trial for geographic atrophy from AMD

Patients with Retinitis Pigmentosa have significantly higher rates of depression compared to the general population

A study of Chicagoland children demonstrated increased rates of myopia progression during the COVID-19 pandemic, perhaps due to increased time spent on screens and indoors.

A retrospective study suggests that semaglutide is not associated with increased risk for non-arteritic anterior ischemic optic neuropathy (NAION).

Black patients were less likely to have conclusive genetic testing compared to White patients when screening for inherited retinal diseases.

Sodium-glucose co-transporter 2 inhibitors were shown to decrease risk of glaucoma compared to other antihyperglycemic agents.

Secondary IOL placement in aphakic children carries potential risks of hyperopic surprise and glaucoma.

A study estimated the objective contribution of vision impairments to dementia risk in a population of older adults.

A population-based study in Korea discovered a link between psoriasis, type 2 diabetes, and conversion to wet AMD.